<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: In order to explore factors associated with the development of <z:hpo ids='HP_0000726'>dementia</z:hpo> in <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) and <z:hpo ids='HP_0000726'>Dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>), we systematically investigated the clinical evaluation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> patients hospitalized in the Department of Neurology at Tottori University Hospital, Japan </plain></SENT>
<SENT sid="1" pm="."><plain>RESULTS: There were 208 patients diagnosed as having <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and 39 patients diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> in this study </plain></SENT>
<SENT sid="2" pm="."><plain>Of the patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>, 67 (32%) developed <z:hpo ids='HP_0000726'>dementia</z:hpo> and only five <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>+ patients were considered to have <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> attributable to <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) or vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="3" pm="."><plain>Fifty-four (81%) PDD patients had <z:hpo ids='HP_0002367'>visual hallucinations</z:hpo> (VH) with or without cognitive fluctuation </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:hpo ids='HP_0003674'>onset</z:hpo> age of parkinsonian motor symptoms of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> <z:hpo ids='HP_0000726'>dementia</z:hpo> (PDD) did not differ from that of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients without <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>There was a significant inverse correlation between the <z:hpo ids='HP_0003674'>onset</z:hpo> age of motor symptoms in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and the <z:hpo ids='HP_0003674'>onset</z:hpo> of their <z:hpo ids='HP_0000726'>dementia</z:hpo> in PDD </plain></SENT>
<SENT sid="6" pm="."><plain>Seventy-five (36%) patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> had experienced VH and most of the PDD patients had experienced VH within 1 year before or after diagnosis of PDD </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These results indicate that aging and VH are important factors associated with <z:hpo ids='HP_0000726'>dementia</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> </plain></SENT>
</text></document>